Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amdocs (DOX) Current Deferred Revenue (2016 - 2025)

Amdocs (DOX) has disclosed Current Deferred Revenue for 14 consecutive years, with $118.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Deferred Revenue rose 3.14% to $118.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $118.9 million, a 3.14% increase, with the full-year FY2025 number at $118.9 million, up 3.14% from a year prior.
  • Current Deferred Revenue was $118.9 million for Q3 2025 at Amdocs, up from $115.2 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $253.7 million in Q3 2022 to a low of $115.2 million in Q3 2024.
  • A 5-year average of $179.2 million and a median of $170.6 million in 2023 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: rose 6.87% in 2022, then plummeted 32.74% in 2023.
  • Amdocs' Current Deferred Revenue stood at $237.4 million in 2021, then rose by 6.87% to $253.7 million in 2022, then tumbled by 32.74% to $170.6 million in 2023, then tumbled by 32.46% to $115.2 million in 2024, then rose by 3.14% to $118.9 million in 2025.
  • Per Business Quant, the three most recent readings for DOX's Current Deferred Revenue are $118.9 million (Q3 2025), $115.2 million (Q3 2024), and $170.6 million (Q3 2023).